Janux Therapeutics News

Janux Therapeutics | 8-K: Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 7 16:28 ET

Janux Therapeutics | 8-K: Current report

Jul 22 17:03 ET

Janux Therapeutics | 8-K: Current report

Jun 28 16:17 ET

Janux Therapeutics | DEFA14A: Others

Jun 17 17:06 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

May 8 15:42 ET

Janux Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 8 09:18 ET

Janux Therapeutics | DEFA14A: Others

Apr 29 16:27 ET

Janux Therapeutics | DEF 14A: Definitive information statements

Apr 29 16:20 ET

Janux Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 8 16:53 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Mar 8 16:16 ET

Janux Therapeutics | 8-K: Current report

Feb 29 17:14 ET

Janux Therapeutics | 8-K: Current report

Feb 28 17:31 ET

Janux Therapeutics | 8-K: Current report

Feb 27 17:27 ET

Janux Therapeutics | 8-K: Current report

Feb 26 22:23 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 7, 2023 16:07 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

Aug 8, 2023 16:17 ET

Janux Therapeutics | 8-K: Current report

Jul 18, 2023 16:16 ET

Janux Therapeutics | 8-K: Current report

Jul 17, 2023 08:06 ET

Janux Therapeutics | 8-K: Current report

Jun 23, 2023 16:36 ET

Janux Therapeutics | 8-K: Current report

Jun 20, 2023 17:17 ET